Rachel Harnes
PhD Researcher
University of Strathclyde
Rachel is a first year researcher within the CMAC team, where her research focuses on the model-based design and manufacture of lipid nanoparticles for cancer therapies. This bridges the gap between nanoparticle design, manufacture, and therapeutic performance.
She graduated from the University of Strathclyde with a BSc in biomedical science in 2025. She also completed a studentship at Nextpharma, learning about the formulation of liquid-filled hard capsules.
